Prostate cancer is a common cancer in men that begins in the prostate gland, a key part of the male reproductive system. Early stages often grow slowly and show few or no symptoms, making detection ...

For many men diagnosed with advanced prostate cancer, one of the biggest concerns is how long treatment will continue working ...

A newly identified interaction between PIM1 and HMGB1 helps prostate cancer cells survive therapy by activating cellular ...

A major international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one of the most common cancers affecting men. The research, published in ...

Nima Sharifi, M.D., director of Cleveland Clinic’s Genitourinary Malignancies Research Center, led research on identifying a new drug target for treating aggressive prostate cancer. (Cleveland Clinic) ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

Neuroendocrine prostate cancer (NEPC) is the most aggressive form of prostate cancer, responsible for up to 20% of therapy-resistant cases and associated with rapid disease progression. It is ...

CHICAGO (Reuters) - A trial of Johnson & Johnson's Zytiga in certain prostate cancer patients showed that it doubled the amount of time they lived without the disease getting worse, potentially ...

The prostate is a small gland that plays an important role in male reproductive anatomy. Prostate problems can have a range of causes, including prostatitis, benign prostatic hyperplasia, and prostate ...